OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	42
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	24
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	21
Age-dependent regulation of hematopoiesis by megakaryocytes	21
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	20
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	19
Disparities in acute myeloid leukemia treatments and outcomes	18
Developmental regulation of primitive erythropoiesis	16
Mesenchymal stromal cells: an update	15
Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential	15
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	13
Platelet lifespan and mechanisms for clearance	13
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	13
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and ‘unclassifiable’ entities	12
The impact of obesity-induced inflammation on clonal hematopoiesis	11
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms	11
Humanized murine models of platelet function	11
Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection	11
Unraveling lipid metabolism for acute myeloid leukemia therapy	11
Advances on the genetic basis of red cell membrane disorders	11
Multifaceted roles of CRISPR technology in blood cancer research	11
High-throughput genotyping tools for red blood cell antigens	10
Stress granules and RNA modifications in blood development and erythroid regeneration	10

Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk	9
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	9
Editorial introduction	9
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
YY1 in hematopoietic stem cells: epigenetic regulation, chromatin architecture, and aging	8
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	8
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning	7
Bidirectional relationship between metabolic and thrombotic disease mechanisms	7
Understanding and targeting erythroid progenitor cells for effective cancer therapy	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Editorial introduction	7
Editorial introductions	7
Modelling arterial thrombus formation in vitro	6
Editorial introduction	6
Current Opinion in Hematology	6
Chediak-Higashi syndrome	6
The state of prediction models in hematologic disease: a worrisome assessment	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
The immunology of PF4 polyanion interactions	6
Red blood cell changes due to cancer and cancer treatments: a narrative review	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
Protease-activated receptors in endothelial health and dysfunction	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	5
Platelet mitochondria: the mighty few	5
Editorial introduction	5
Platelet transfusion	5
Membrane phospholipids in the regulation of tissue factor procoagulant function	5
Novel approaches to measure transfusion effectiveness	5
Editorial introduction	5
The fulfilled promise and unmet potential of umbilical cord blood	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	5
Epigenetics of hematopoietic stem cell aging	5
Advances in the pathophysiology and treatment of anaemia in multiple myeloma	4
Red cell extracellular vesicles and coagulation activation pathways	4
The impact of prenatal inflammation on hematopoietic development	4
Hematopoietic stem cell collection for sickle cell disease gene therapy	4
Donor selection in allogeneic stem cell transplantation	4
Proteomic perspectives on platelet reactivity: towards precision thrombosis research	4
Age-related micro-environmental changes as drivers of clonal hematopoiesis	4
Myeloproliferative neoplasms in the young: unique disease patterns and therapeutic strategies	4
Aging in the bone marrow: when hematopoiesis gets clonal	4
Macrocytic anemias	4

BEACH domain-containing proteins: emerging roles in hematopoiesis and immune homeostasis	4
Platelet Fc gamma RIIA: time to go beyond the unknown	3
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	3
G protein-coupled receptor-mediated platelet thrombus formation	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
Immunologic effects of red blood cell and platelet transfusions in neonates	3
N6-methyladenosine in hematological malignancies: a concise review	3
The role of stem cell transplantation in the modern management of multiple myeloma	3
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	3
Fibrin formation and lysis in hyperglycaemia – molecular and cellular drivers	2
Editorial introductions	2
Editorial introduction	2
Editorial introductions	2
Editorial Introductions	2
From bud to stem: dynamics of hematopoietic stem cells that drive homing and mobilization	2
Scoring systems to predict thrombotic complications in solid tumor patients	2
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology	2
Roles of megakaryocytes and platelets in myeloproliferative neoplasms	2
Pediatric acute myeloid leukemia – novel approaches	2
Direct megakaryopoiesis	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
New molecules in the therapy of chronic graft-versus-host disease	2
Histological differences among thrombi in thrombotic diseases	2